Trends in tuberculosis - United States, 2011

Morbidity and Mortality Weekly Report

Volumn 61, Issue 11, 2012, Pages 181-185

  Miramontes, Roque ^a   Price, Sandy F ^a   Jeffries, Carla ^a   Navin, Thomas R ^a   Oramasionwu, Gloria E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASIAN; ETHNOLOGY; HEALTH DISPARITY; HEALTH SURVEY; HISPANIC; HUMAN; INCIDENCE; STATISTICS; TUBERCULOSIS; UNITED STATES;

AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; TUBERCULOSIS; UNITED STATES;

EID: 84859140624     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Reported tuberculosis in the United States, 2010. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at http://www.cdc.gov/tb/statistics/reports/2010/default.htm. Accessed February 21, 2012.
2. CDC. Decrease in reported tuberculosis cases-United States, 2009. MMWR 2010;59:289-94.
3. US Census Bureau. Current estimates data. Available at http://www.census.gov/popest/data/national/totals/2011/index.html. Accessed February 2, 2012.
4. CDC. A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989;38(No. S-3).
5. Hill AN, Becerra JE, Castro KG. Modelling tuberculosis trends in the USA. Epidemiol Infect 2012:1-11.
6. Cegielski JP, Griffith DE, McGaha PK, et al. Eliminating tuberculosis, one neighborhood at a time. Am J Public Health 2012 (In press).
7. CDC. CDC immigration requirements: technical instructions for tuberculosis screening and treatment. Using cultures and directly observed therapy. US Department of Health and Human Services, CDC; 2009. Available at http://www.cdc.gov/immigrantrefugeehealth/pdf/tuberculosis-ti-2009.pdf. Accessed February 16, 2012.
8. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365:2155-66.
9. CDC. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR 2011;60:1650-3.
10. CDC. Treatment of tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR 2003;52(No. RR-11).